AMAndrzej Milewicz

Andrzej Milewicz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrzej Milewicz has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum Vitamin D status in women with the polycystic ovary syndrome

    by Justyna Kuliczkowska-Plaksej, Andrzej Milewicz, Renato Pasquali, Agnieszka Lenarcik-Kabzda, Lukasz Laczmanski, Felicja Lwow, Diana Jedrzejuk, Marek Bolanowski

    Objective: To measure the levels of 25-hydroxyvitamin D (25(OH)D) and vitamin D binding protein (VDBP) and assess their relationships with metabolic features in patients with the polycystic ovary syndrome (PCOS). Methods: 267 women, aged 20–35 years (24.7±4.9): 167 with PCOS, 100 healthy women as a control group were studied. Study groups were divided according to body mass index (BMI). Biochemical and hormonal parameters, 25(OH)D, VDBP were measured. Free and bioavailable 25(OH)D were calculated using the mathematical equations. The percentage of body fat and visceral fat deposit were assessed by DXA. Results: In the normal weight control group total, free and bioavailable 25(OH)D were significantly (PPP<0.001) were lower in the overweight/obese subgroups than in the normal weight one. VDPB was negatively correlated with fasting insulin, positively with SHBG in control group. In PCOS group, VDPB was negatively correlated with abdominal fat deposit, BMI, fasting glucose and insulin and positively with HDL and SHBG. Conclusions: Despite lower total 25(OH)D in obese PCOS women, all women with PCOS (lean and obese) had comparable free and bioavailable 25(OH)D which might be a result of concomitantly lowered serum VDBP levels in obese PCOS women. VDBP might play important role in the regulation of availability of active fractions of 25(OH)D in PCOS women. VDBP is strongly associated with cardio–vascular risk factors such as BMI, waist circumference, visceral fat, fasting insulin in women with PCOS.

  • Lipid accumulation product (LAP) and waist circumference to height ratio (WHtR) associated with free androgen index but not with serum testosterone and androstendione in women with PCOS

    by Justyna Kuliczkowska-Plaksej, Andrzej Milewicz, Lukasz Laczmanski, Diana Jedrzejuk, Felicja Lwow, Marek Bolanowski

    Introduction: Polycystic ovary syndrome (PCOS) is associated with metabolic disorders such as insulin resistance, hyperinsulinemia, dyslipidemia and central obesity which increase the risk of cardiovascular diseases (CVD). Lipid accumulation product (LAP) and waist circumference to height ratio (WHtR) are novel CVD risk predictors based on the assessment of waist circumference, height and serum triglycerides. The aim of our study was to evaluate the LAP and WHtR associations with hyperandrogenemia in women with PCOS. Materials: The study group consists of 161 women with PCOS diagnosed according to the Rotterdam criteria aged 24.7±4.9. We measured serum testosterone, androstendione, sex hormone binding globulin (SHBG), lipid profile by commercial kits. Free androgen index (FAI) was calculated by standard formula. LAP cut-off value was 34.5, and for WHtR was 0.5. Study group was divided into two subgroups according to FAI value ≥5.0 and separately into three subgroups according to serum testosterone and androstendione concentrations. Results: Women with PCOS and FAI over 5.0 had significantly higher LAP values than women with FAI below 5 (84.75% vs 15.25% respectively, P5 is associated with fivefold increased risk of high LAP values. Similarly, PCOS women with FAI>5 had higher WHtR, which suggests that increased FAI value is associated with higher WHtR (OR–3.55, P. Conclusions: Hyperandrogenemia expressed as FAI ≥5.0 is associated with significantly higher values of novel CVD risk predictors – LAP and WHtR in women with PCOS. Serum SHBG level as well as FAI value are good predictors of CVD risk in women with PCOS.

  • What factors influenced on femoral neck bone mineral density in postmenopausal women?

    by Diana Jedrzejuk, Felicja Lwow, Anna Arkowska, Urszula Mieszczanowicz, Andrzej Milewicz

    Postmenopausal osteoporosis is a condition that appears as a result of a sudden reduction in E2 production by the ovaries. The earliest is manifested by the reduction of lumbar BMD; mostly consisted of trabecular bone. Proximal femur is built mostly of cortical bone, and so is aging more slowly, but femoral fracture more often lead to disability and death. The aim of the study was to check which from the anthropometric, hormonal and biochemical markers have the influence on the femoral neck BMD in postmenopausal women. The study included 325 healthy postmenopausal women (menopause >1 year ago) a random selected of women aged 50–60. The exclusion criteria were: smoking tobacco, HRT, ovariectomy, hyperparathyroidism, neoplasm, taking of anti cholesterol and antidiabetic drugs. BMI was calculated and waist circumference was measured. The femoral neck and total body BMD were performed using DXA method. Gynoid and android fat deposits were calculated. We had determined the concentrations of FSH, E2, DHEAS, T, SHBG, insulin, leptin, adiponectin, IL6, TNF-α and glucose using commercial kits. HOMA. E2:T ratio, FAI and FEI were calculated. We have shown a negative correlation between the femoral neck BMD and SHBG, and positive with body weight, BMI, % of body fat, android and gynoid fat deposits, waist, fasting glucose concentration and E2:T ratio. The TNF α concentration correlate statistically significantly negatively with femoral neck BMD, and leptin-positively. After the multiple regression analysis we found that body weight, TNF-α, glucose concentration and E2:T ratio are independent factors affecting femoral neck BMD in postmenopausal women. Conclusions: anthropometric factors stronger than hormonal influence on femoral neck BMD in postmenopausal women. The independent factors affecting femoral BMD is body weight (P=0.00000), E2:T ratio (P=0.00149), TNF-α (P=0.0172) and glucose concentrations (P=0.0199).

  • VDR gene polymorphisms in Alzheimer's disease: pilot study

    by Lukasz Laczmanski, Marta Jakubik, Joanna Rymaszewska, Grazyna Bednarek-Tupikowska, Felicja Lwow, Natalia Sloka, Andrzej Milewicz

    Aggravation of the symptoms of Alzheimer’s disease may also underlie the functioning of receptors associated with calcium and vitamin D. Therefore, it seems reasonable to study the correlation of polymorphisms of vitamin D receptor (VDR) and calcium receptor (CASR) with symptoms of AD. Alzheimer’s disease, vitamin D deficiency and osteoporosis often coexist in the patient. Research suggests that vitamin D deficiency is much more frequent in the patients with AD. Expression of VDR gene occurs in a neuronal and a glial cells. VDR belongs to the nuclear receptor superfamily and acts as a ligand activated transcription factor. During the project it was selected a 40 patients and a group of 40 healthy volunteers. There are many polymorphisms in the VDR gene. In the present work we focused on assessing the prevalence of four of them relating to the regulation of expression of this gene: TaqI, ApaI, FokI and BsmI. Distribution of all polymorphisms were obtained according to Hardy–Weinberg low (ApaI: χ2=2.54, P=0.1111, TaqI: χ2=1.21, P=0.2412, BsmI: χ2=0.57, P=0.4490, and FokI: χ2=1.23, P=0.2680). We didn’t observe any significant differences in the distribution of individual genotypes of the VDR polymorphisms in patients with Alzheimer’s disease compared to control group. Project requires further research with a larger group of patients and control group. The project was funded by the National Science Centre, grant number. UMO-2011/01/B/NZ7/00656.

  • CNR1 polymorphisms and metabolic disorders in woman with PCOS-preliminary report

    by Andrzej Milewicz, Łukasz Łaczmański, Agnieszka Lenarcik, Justyna Kuliczkowska, Anna Trzmiel-Bira, Barbara Stachowska, Diana Jędrzejuk, Ewa Sadowska, Katarzyna Kolackov, Maurycy Pawlak, et al.

    The endocannabinoid system has been suspected to contribute to the association of visceral fat accumulation with metabolic diseases. Insulin resistance play important role in etiology in PCOS. The aim of our study was developed the role of CNR1 polymorphisms (rs806368, rs12720071, rs1049353, 806381, rs10485170, rs6454674, rs2023239) in metabolic disorders in woman with PCOS. 88 woman (20–35 years old) with PCOS (recognized using Rotterdam criteria) and 77 woman (20–35 years old) as homogenous controls group were study. Lipids profile and carbohydrate metabolism in serum using standard methods were study. Genomic DNA were isolated using standard method. To amplify the genetic material of the PCR technique was used. To polymorphisms identification minisequencing was used. Reaction products were separated on Genetic Analyser ABI 3100. For statistic analysis ANOVA test was used. In polymorphism rs12720071 eight woman with PCOS present genotype G/G in contrast to control we can’t find such a genotype. These genotype in polymorphism rs1049353 in PCOS group present a higher WHR vs other genotype in contrast to control group. Also other polymorphism rs 10485170 in genotype A/G show significantly lower LDL cholesterol levels in controls but not in woman with PCOS. In polymorphism rs2023239 genotype C/C was connected with elevated levels of free androgens index in PCOS patients. Our preliminary results can suggest the potential role of CNR1 polymorphisms PCOS etiology what need further study.

    • 1 January 2013
      • Vol. 64  (2) , 82-93

    The reference values of sex hormones and SHBG serum levels in subjects over 65 years old - The PolSenior Study.

    by Andrzej Milewicz, Barbara Krzyżanowska-Świniarska, Tomasz Miazgowski, Diana Jędrzejuk, Anna Arkowska, Urszula Mieszczanowicz, Ewa Bar-Andziak

    Over the last decade, average life expectancy has continuously increased. There has been no data on normal sex hormone (SH) levels in a Polish elderly population. In this study, we assessed SH in the PolSenior cohort to determine normal reference ranges in relation to gender, age, and cardiovascular disease risk factors (CVDRFs). The study was performed with 4,352 participants (2,168 men and 2,088 women), aged from 55 to over 90 years, stratified in five-year age groups. Pre-elderly subjects (55-59 years of age) served as the reference group. We assessed total testosterone (TT), estradiol (TE2) and DHEA-S (by RIA) SHBG and FSH (by IRMA) and calculated free androgen and free estrogen indices (FAI and FEI). Percentage body fat (%BF) was measured by bioelectric impedance analysis. The CVDRFs assessment included blood pressure and biochemical (blood glucose, high-density lipoproteins, triglycerides) and anthropometric (waist circumference) components of the metabolic syndrome. TT was low in 19.9%, normal in 78.2%, and high in 1.8% of men. TE2 was low in 94.6% of women. Age and CVDRFs significantly influenced values of SHBG, FSH, TT, FAI, FEI, and DHEA-S in men, while in women values of FSH, TT and TE2 did not change. BMI and %BF affected SH regardless of the age groups and CVDRFs. Our findings suggest that the reference ranges stratified by the five-year age bands seem more accurate than those given for the overall population over 60 years of age. The clinical relevance of these reference ranges increases when they are considered in relation to CVDRFs, BMI and %BF.


    • 1 March 2012
      • Vol. 37  (1) , 93-101

    Menopausal obesity and metabolic syndrome - PolSenior study.

    by A Milewicz

    Obesity is a common problem and its health consequences depend on the phenotype of obesity. Clinical aspects of three phenotypes of obesity: upper body (visceral), lower body (healthy) and metabolic obesity with normal weight are discussed. The PolSenior study and other data show that the incidence of obesity increases during hormonal climacteric transformation with special emphasis on visceral (72%) and metabolic obesity with normal weight (16%). The etiology of menopausal obesity and fat redistribution with an increase incidence of menopausal metabolic syndrome is presented. The role of sex hormones and SHBG of fat mass and fat distribution in postmenopausal women is discussed on the basis of PolSenior study. The diagnostic-therapeutic algorithm for climacteric women is recommended according to cardiovascular diseases risk (CVD), elevated waist circumference, serum triglicerides, decreased HDL cholesterol, elevated fasting glucose, HOMA over 1.69 and BP over 130/80 mmHg. In women with CVD risk factors the metformin therapy is a golden standard.


  • Open Access

    In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis

    by A Lewiński, A Brona, Kc Lewandowski, E Skowrońska-Jóźwiak, A Milewicz

    Matrix metalloproteinases (MMPs), together with their tissue inhibitors (TIMPs), remodel extracellular matrix under physiological and pathological conditions and are implicated in pathogenesis of cardiovascular diseases, cancer and in chronic inflammation. We have endeavoured to assess whether concentrations of MMPs, TIMPs, and anti-inflammatory adiponectin are altered by pharmacological treatment of acute thyrotoxicosis or by radioiodine therapy (RIT).


    • 1 January 2012
      • Vol. 63  (6) , 447-55

    Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population.

    by Grażyna Bednarek-Tupikowska, Barbara Stachowska, Tomasz Miazgowski, Barbara Krzyżanowska-Świniarska, Barbara Katra, Maciej Jaworski, Justyna Kuliczkowska-Płaksej, Alicja Jokiel Rokita, Małgorzata Tupikowska, Marek Bolanowski, et al.

    In the 1980s, the idea evolved that some individuals with normal weight (Metabolically Obese, Normal-Weight), who probably have increased abdominal fat, have metabolic disturbances related to obesity. This observation initiated the concept of the metabolically obese but normal-weight syndrome (MONW). Since then, there have been only a few studies in non-obese subjects. MONW men and women should be regarded as at high risk for cardiovascular disease. A group of 854 randomly chosen non-obese men and women, 20-40 years of age, was selected from three different areas of Poland - Szczecin, Krakow and Wroclaw. All subjects were interviewed and underwent physical examination, anthropometric measurements (waist circumference, hip circumference, BMI and WHR) as well as densitometry (total body DPX, total fat, android/gynoid deposit). Serum level of fasting glucose and insulin, indices of insulin sensibility (QUICKI) and insulin resistance (HOMA, FIRI), total cholesterol, triglycerides and HDL-C were measured using commercially available kits. LDL-C level was calculated using Friedewald's formula. The total amassed fatty tissue and its android deposit was found to be significantly greater in MONW men and women. MONW women were found to exhibit increased levels of triglycerides and LDL-C but lower levels of HDL-C. In women with excess abdominal fat (EAF), fasting glucose and insulin levels, HOMA and FIRI were considerably higher, while QUICKI was lower. Triglyceride and LDL-C levels were also higher while HDL-C levels were lower. In men with EAF, increased levels of total cholesterol and LDL-C were confirmed. The occurrence of MONW is contingent upon the diagnosis criterion and increases when the criterion represents the value of HOMA - 21.76% in women and 31.42% in men. The frequency of MONW occurrence is lower when the criterion for abdominal fat content limit is used, amounting to 15.78% in women and 7.83% in men.


    • 1 June 2011
      • Vol. 82  (6) , 426-9

    Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome.

    by Bozena Bidzińska-Speichert, Agnieszka Lenarcik, Urszula Tworowska-Bardzińska, Ryszard Slezak, Grazyna Bednarek-Tupikowska, Andrzej Milewicz, Katarzyna Krepuła

    The pathogenesis of PCOS has not been definitively determined and includes a number of genes linked with steroidogenesis, regulation of gonadotropin secretion, actions of insulin, obesity as well as chronic inflammatory processes. Some authors indicate that PPARgamma play a role in insulin sensitivity and are probably involved in hyperandrogenism in PCOS. The aim of the study was to assess the frequency of the Pro12Ala and Pro115Gln PPARgamma2 gene polymorphisms in women with PCOS. 54 PCOS women and 51 healthy women were recruited. Genetic studies to detect Pro12Ala and Pro115Gln PPARgamma2 gene polymorphism were performed. In the whole studied group the Pro115Gln polymorphism of the PPARgamma2 gene was not found. The frequency of the Pro12Ala polymorphism was estimated at 26.47% in the controls and at 23.15% in the PCOS patients. Women from the control and PCOS groups with BMI > or = 30 had statistically higher occurrence of the Ala allele than women with BMI <30 (38.80% versus 12.50% and 38.23% versus 18.75%). The frequency of the Pro12Ala polymorphism observed in the sample of women from the Lower Silesian population was significantly higher than in the majority of European populations.